Society of Nuclear Medicine--54th annual meeting. New directions in molecular imaging of the brain.
Croydon
Léonie
L
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. leonie.croydon@thomson.com
D000682:Amyloid / Q000032:analysis; D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology; D001923:Brain Chemistry; D002986:Clinical Trials as Topic; D003704:Dementia / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D006801:Humans; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000032:analysis; D049268:Positron-Emission Tomography / Q000379:methods / Q000639:trends; D011877:Radionuclide Imaging / Q000379:methods* / Q000639:trends; D017480:Receptors, sigma / Q000032:analysis / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods / Q000639:trends
D000682:Amyloid; D050484:Norepinephrine Plasma Membrane Transport Proteins; D017480:Receptors, sigma; C493227:SLC6A2 protein, human